PD40-12 DEFINING THE IMPACT OF PERIOPERATIVE MORBIDITY FROM CYTOREDUCTIVE NEPHRECTOMY ON THE TIMING OF SYSTEMIC THERAPY: A CONTEMPORARY SERIES FROM FIVE CENTERS
2021
INTRODUCTION AND OBJECTIVE:For metastatic renal cell cancer (mRCC) patients considering cytoreductive nephrectomy (CN), perioperative morbidity may delay or preclude post-operative systemic therapy...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI